3 European Growth Companies With Up To 38% Insider Ownership

As the European market navigates through a landscape shaped by geopolitical tensions and fluctuating energy prices, investor focus has shifted back to corporate fundamentals with the onset of earnings season. In this context, growth companies with significant insider ownership can offer unique insights into management confidence and potential long-term value creation.

Top 10 Growth Companies With High Insider Ownership In Europe

Name	Insider Ownership	Earnings Growth
Pharma Mar (BME:PHM)	12.1%	39.9%
OSE Immunotherapeutics (ENXTPA:OSE)	23%	73.3%
Kuros Biosciences (SWX:KURN)	23.7%	65.6%
KebNi (OM:KEBNI B)	16.3%	103.8%
Gold Road International (OB:GOLDR)	36.7%	89.8%
CTT Systems (OM:CTT)	17.4%	55.3%
Clavister Holding AB (publ.) (OM:CLAV)	19.4%	41.1%
Bonesupport Holding (OM:BONEX)	10.6%	32.4%
Bergen Carbon Solutions (OB:BCS)	11.9%	52%
2G Energy (XTRA:2GB)	13.4%	35.6%

Click here to see the full list of 204 stocks from our Fast Growing European Companies With High Insider Ownership screener.

Here's a peek at a few of the choices from the screener.

Reway Group (BIT:RWY)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Reway Group S.p.A. operates through its subsidiaries to focus on road and motorway infrastructure rehabilitation in Italy, with a market cap of €395.81 million.

Operations: The company's revenue segments include €267.81 million from services and €1.90 million from the sale of goods and materials.

Insider Ownership: 18.2%

Reway Group's earnings are forecast to grow at 13.37% annually, surpassing the Italian market's 9.9% growth rate, while trading at 43.4% below estimated fair value. Recent earnings show a rise in sales to €137.29 million for H1 2026 from €108.97 million a year prior, though net income declined slightly to €10.72 million from €11.83 million. Renaissance AIFM S.a.r.l.'s acquisition of Reway Group indicates strong insider confidence and potential strategic growth opportunities.

• Take a closer look at Reway Group's potential here in our earnings growth report.
• The valuation report we've compiled suggests that Reway Group's current price could be quite moderate.

TTS (Transport Trade Services) (BVB:TTS)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: TTS (Transport Trade Services) S.A. is a Romanian company that offers freight forwarding services, with a market capitalization of RON1.31 billion.

Operations: The company's revenue is derived from forwarding services (RON443.34 million), port operations (RON136.10 million), and river transport (RON299.61 million).

Insider Ownership: 38.4%

Transport Trade Services shows promising growth potential, with earnings expected to grow significantly at 32.7% annually, outpacing the broader market. Despite trading slightly below its fair value, TTS recently became profitable, reporting a net income of RON 4.36 million for H1 2026 compared to a loss last year. Revenue is projected to increase by 7.9% annually, exceeding market averages but remaining below high-growth thresholds.

• Click here to discover the nuances of TTS (Transport Trade Services) with our detailed analytical future growth report.
• Our comprehensive valuation report raises the possibility that TTS (Transport Trade Services) is priced higher than what may be justified by its financials.

BioArctic (OM:BIOA B)

Simply Wall St Growth Rating: ★★★★★★

Overview: BioArctic AB (publ) focuses on developing biological drugs for central nervous system disorders in Sweden and has a market cap of SEK26.62 billion.

Operations: The company's revenue is primarily derived from its biotechnology segment, amounting to SEK1 billion.

Insider Ownership: 32%

BioArctic's growth outlook is robust, with earnings projected to rise significantly at 67.1% annually, surpassing the Swedish market average. Despite recent financial challenges, including a net loss of SEK 11.17 million for Q2 2026 and decreased sales, its innovative Alzheimer's treatment Leqembi shows potential for expansion in Europe and Japan. The strategic partnership with Eisai enhances BioArctic's market reach and product development capabilities, while insider ownership remains stable without significant recent trading activity.

• Delve into the full analysis future growth report here for a deeper understanding of BioArctic.
• Our valuation report unveils the possibility BioArctic's shares may be trading at a premium.

Make It Happen

• Click this link to deep-dive into the 204 companies within our Fast Growing European Companies With High Insider Ownership screener.
• Searching for a Fresh Perspective? Uncover 23 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com